Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jan 11, 2025
Date Accepted: Apr 8, 2025

The final, peer-reviewed published version of this preprint can be found here:

Effectiveness of Telemedicine Interventions on Motor and Nonmotor Outcomes in Parkinson Disease: Systematic Review and Network Meta-Analysis

Dou J, Wang J, Gao X, Wang G, Bai Y, Liang Y, Yang K, Yang Y, Zhang L

Effectiveness of Telemedicine Interventions on Motor and Nonmotor Outcomes in Parkinson Disease: Systematic Review and Network Meta-Analysis

J Med Internet Res 2025;27:e71169

DOI: 10.2196/71169

PMID: 40460428

PMCID: 12174881

Effectiveness of Telemedicine Interventions on Motor and Non-Motor Outcomes in Parkinson’s Disease: A Systematic Review and Network Meta-Analysis

  • Jiejie Dou; 
  • Junyu Wang; 
  • Xianqi Gao; 
  • Guotuan Wang; 
  • Ying Bai; 
  • Yixin Liang; 
  • Kunyi Yang; 
  • Yong Yang; 
  • Lin Zhang

ABSTRACT

Background:

Parkinson’s disease (PD) presents motor and non-motor challenges that significantly affect quality of life. Telemedicine has emerged as a promising approach to deliver interventions, including exercise (eExercise), cognitive training (eCognitive), and teleconsultations (eVisits), yet their comparative effectiveness remains unclear.

Objective:

To evaluate the effectiveness of telemedicine interventions on motor and non-motor outcomes in PD and compare the efficacy of eExercise, eCognitive, and eVisits.

Methods:

A systematic review and network meta-analysis were conducted by searching PubMed, MEDLINE, Embase, Cochrane CENTRAL, and Web of Science through November 2024. Randomized controlled trials comparing telemedicine interventions with usual care were included. Outcomes assessed included total motor symptoms, quality of life, cognitive function, depressive and anxiety symptoms, fear of falling, 6-minute walk test, walking velocity, balance ability, and time-up-and-go.

Results:

Twenty-three studies involving 1330 participants were included. Telemedicine significantly improved total motor symptoms (SMD= -0.61), cognitive function (SMD= 0.58), depressive symptoms (SMD= -0.46), anxiety symptoms (SMD= -0.57), fear of falling (SMD= -0.48), and 6-minute walk test performance (mean difference=18.98 meters). The network meta-analysis revealed that eExercise was most effective for improving total motor symptoms (SMD= -1.01) and 6-minute walk test performance. eCognitive was most effective for enhancing quality of life (SMD= 0.39), cognitive function (SMD= 1.02), and reducing depressive (SMD= -1.28) and anxiety symptoms (SMD= -1.07). eVisits had limited impact across outcomes.

Conclusions:

Telemedicine is effective for improving motor and non-motor outcomes in PD. eExercise is optimal for motor function and physical performance, while eCognitive is most effective for psychological and cognitive challenges. These findings highlight the importance of tailoring telemedicine programs to address specific therapeutic needs in PD management. Clinical Trial: PROSPERO CRD42024628687; https://www.crd.york.ac.uk/PROSPERO/#recordDetails


 Citation

Please cite as:

Dou J, Wang J, Gao X, Wang G, Bai Y, Liang Y, Yang K, Yang Y, Zhang L

Effectiveness of Telemedicine Interventions on Motor and Nonmotor Outcomes in Parkinson Disease: Systematic Review and Network Meta-Analysis

J Med Internet Res 2025;27:e71169

DOI: 10.2196/71169

PMID: 40460428

PMCID: 12174881

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.